Gastrointestinal Systems Market Analysis

Application (Surgical Oncology, Pain Management, Cardiology & Cardiac Rhythm Management, Cosmetology, Gynecology, and Others)

The surgical oncology segment is estimated to gain the largest market share of 32% by the end of 2036. The growth of the segment can be attributed to the increasing prevalence of cancer across the globe. RFA is frequently utilized in surgical oncology as a complement to surgery, especially for the treatment of colon, liver, and pancreatic cancer. For instance, RFA can be used to either reduce the size of tumors before surgical resection or to remove any malignant tissue that may be left over after surgery. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years. By 2040, there will be over 16 million cancer-related deaths globally and more than 29 million new instances of cancer annually.

End-User (Hospitals, Cancer Specialty Clinic, and Others)

The hospital segment is expected to hold the largest share of 52% during the forecast period. Hospitals are well-equipped to supply the specific tools and skilled medical personnel that treatments involving the digestive system normally call for. Besides this, if there are any difficulties, patients receiving gastrointestinal RFA operations may need to spend the night in the hospital for observation and monitoring. As a result, it is projected that this would generate a lot of prospects for the segment's growth in the years to come.

Our in-depth analysis of the global market includes the following segments:

By Type	Benchtop Trolley
By Application	Surgical Oncology Pain Management Cardiology & Cardiac Rhythm Management Cosmetology Gynecology Others
By End User	Hospitals Cancer Specialty Clinic Others

Frequently Asked Questions (FAQ)

Growing preference for minimally invasive procedures and the growing prevalence of gastrointestinal diseases are the major factors driving the market growth.

The market size of gastrointestinal radiofrequency ablation systems is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are ATRICURE, INC, Royal Philips, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Japan Lifeline Co. Ltd, Medtronic Japan Co. Ltd, Olympus Corporation, Astellas Pharma Inc. and others

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Gastrointestinal Systems Market Analysis